K. Handley

发表

Mixed effect modelling of proteomic mass spectrometry data by using Gaussian mixtures

I. Dryden, D. Schadendorf, S. Mian, 2010 .

Intratumoral stromal morphometry predicts disease recurrence but not response to 5‐fluorouracil—results from the QUASAR trial of colorectal cancer

D. Treanor, D. Kerr, R. Gray, 2018, Histopathology.

Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial

Rajan K. Patel, J. Cleland, P. Mark, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study

I. Nagtegaal, R. Gray, C. Punt, 2017, BMJ Open.

FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report.

R. Gray, B. Warren, P. Quirke, 2011, Journal of Clinical Oncology.

Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study

A. Darzi, R. Peto, P. Ziprin, 2020, The lancet. Gastroenterology & hepatology.

Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study

Rajan K. Patel, P. Mark, N. Ives, 2019, BMC Nephrology.

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

H. Earl, D. Rea, J. Yarnold, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial)

S. Lawrie, P. Ziprin, D. Miskovic, 2017, British Medical Journal.

Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)

P. Hayes, S. Jowett, P. Richardson, 2019, BMJ open gastroenterology.

Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer.

R. Gray, P. Quirke, R. Riddell, 2021, Clinical colorectal cancer.

aTTom (adjuvant Tamoxifen--To offer more?): Randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer--Preliminary results

H. Earl, R. Gray, C. Poole, 2008 .

A Multicentre Randomised Controlled Trial Comparing Safety, Efficacy, and Cost-Effectiveness of the Surgisis® Anal Fistula Plug versus Surgeon's Preference for Transsphincteric Fistula-in-Ano: The FIAT Trial

J. Scholefield, C. Hulme, M. Kaur, 2019, SSRN Electronic Journal.

Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial

Michael E. Williamson, Richard E. McCormick, J. Canny, 2020, Lancet.

Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT.

R. Gray, D. Jayne, J. Scholefield, 2019, Health technology assessment.

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

D. Kerr, S. Shak, F. Baehner, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

D. Kerr, R. Gray, P. Quirke, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The RESPITE trial: remifentanil intravenously administered patient-controlled analgesia (PCA) versus pethidine intramuscular injection for pain relief in labour: study protocol for a randomised controlled trial

J. Daniels, C. MacArthur, K. Handley, 2016, Trials.

Intravenous remifentanil patient-controlled analgesia versus intramuscular pethidine for pain relief in labour (RESPITE): an open-label, multicentre, randomised controlled trial

J. Daniels, C. MacArthur, K. Handley, 2018, The Lancet.

Dexamethasone reduces emesis after major gastrointestinal surgery (DREAMS)

D. Morton, K. Handley, L. Magill, 2013, Trials.

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials

J. Barrett, D. Kerr, R. Gray, 2016, The Journal of pathology.

Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease

C. Clarke, N. Ives, R. Stowe, 2011, Movement disorders : official journal of the Movement Disorder Society.

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.

C. Clarke, N. Ives, R. Stowe, 2010, The Cochrane database of systematic reviews.

CREST: Randomised phase III study of stenting as a bridge to surgery in obstructing colorectal cancer--Results of the UK ColoRectal Endoscopic Stenting Trial (CREST).

R. Gray, D. Morton, K. Handley, 2016 .

Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial

D. Evans, P. Quirke, S. Richman, 2019, Histopathology.

A Multicenter Randomized Controlled Trial Comparing Safety, Efficacy, and Cost-effectiveness of the Surgisis Anal Fistula Plug Versus Surgeon's Preference for Transsphincteric Fistula-in-Ano

R. Gray, D. Jayne, J. Scholefield, 2020, Annals of surgery.

Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision

A. Darzi, R. Peto, P. Ziprin, 2022, The Lancet. Healthy longevity.

Accuracy of radiological staging in identifying high‐risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience

R. Gray, B. Warren, P. Quirke, 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

S. Laurberg, R. Gray, P. Quirke, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review.

Kelsey L. Grantham, M. Taljaard, J. McKenzie, 2021, The Lancet. Global health.

Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

H. Earl, D. Rea, R. Gray, 2013 .

I. Nagtegaal, R. Gray, C. Punt, 2017, BMJ Open.

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

D. Kerr, S. Shak, F. Baehner, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial

R. Gray, B. Warren, P. Quirke, 2012 .

Statistical analysis of surface-enhanced laser desorption/ionization (SELDI) protein chip data from breast cancer cell lines exposed to chemotherapeutic agents

I. Dryden, R. Rees, W. Browne, 2002 .